Why the study?
Primary cardiac undifferentiated pleomorphic sarcoma is an extremely rare malignant tumor with very poor prognosis.
Does repeated surgical resection combined with Pazopanib chemotherapy enable long-term survival in a patient with recurrent primary cardiac undifferentiated pleomorphic sarcoma?
Case Report (n=1)
No
Does repeated surgical resection combined with Pazopanib chemotherapy enable long-term survival in a patient with recurrent primary cardiac undifferentiated pleomorphic sarcoma?
Repeated surgical resections combined with Pazopanib chemotherapy may enable long-term survival in patients with highly recurrent primary cardiac undifferentiated pleomorphic sarcoma.
May support repeated resection plus Pazopanib in select recurrent cardiac UPS cases; hypothesis-generating and should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Murakami et al. (2022) conducted a case report in Primary cardiac undifferentiated pleomorphic sarcoma (n=1). Surgical resection and Pazopanib was evaluated on Survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: